This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John P. Minton, MD, PhD; Walter B, Hamilton; Armando Sardi, MD; Carol Nieroda, MD; Brenda Sickle-Santanello, MD; Patrick J. O'Dwyer, MD

Arch Surg. 1989;124(1):46-48.

Abstract
• Metastatic carcinoma to the liver is generally considered to be associated with a poor prognosis, with five-year survival of only 20% to 30% after resection of solitary lesions. Ninety-eight consecutive patients underwent the surgical removal of one to 13 metastatic lesions from the liver. A rising carcinoembryonic antigen level was considered an indication for reexploration. All gross tumor was removed in every patient; 66 had more than one metastasis. Survival was unexpectedly high: 91 of 98 were alive at 12 months, 50 (70%) of 71 at 13 to 24 months, 23 (66%) of 36 at 25 to 36 months, 14 (74%) of 19 at 37 to 48 months, six (60%) of ten at 49 to 60 months, four (80%) of five at 61 to 72 months, and two (50%) of four 73 to 84 months after resection of multiple liver metastases. The procedure appears to be a safe and, in some patients, beneficial surgical technique for the removal of multiple hepatic metastases.

(Arch Surg 1989;124:46-48)

Author Affiliations
From the Department of Surgery, Ohio State University College of Medicine, Columbus.

Footnotes
Accepted for publication Sept 21, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 25, 1988.

Reprint requests to Department of Surgery, Ohio State University College of Medicine, 410 W Tenth Ave, Columbus, OH 43210 (Dr Minton).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?